GlassScriptPhysician profile
Caroline Y Yang
NPI 1194818955
$2,644.71
in general payments reported to CMS, 2019-2025
14 companies · $274 in 2025
The $274 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $297 · 2020: $22.17 · 2021: $300 · 2022: $625 · 2023: $664 · 2024: $462 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,346 · Education: $52.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,346.47 |
| Education | $52.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,115.75 | 2022-2025 | Inspire |
| Stryker Corporation | $295.58 | 2019-2021 | |
| Allergan, INC. | $267.23 | 2022 | |
| Intersect Ent, INC. | $189.38 | 2019-2021 | |
| Alk-Abello, INC | $173.02 | 2019-2024 | Pre-Pen, Alternaria Tenuis, Timothy, Standardized |
| Genzyme Corporation | $140.20 | 2023-2025 | |
| Medtronic, INC. | $123.69 | 2022-2024 | Nuvent, Propel |
| Regeneron Healthcare Solutions, INC. | $122.79 | 2022-2025 | Dupixent |
| Sanofi-Aventis U.S. LLC | $52.99 | 2023 | |
| Smith+Nephew, INC. | $49.74 | 2019-2023 | |
| Glaxosmithkline, LLC. | $37.68 | 2021-2023 | Nucala |
| Abbvie INC. | $32.69 | 2024 | |
| Kaleo, INC. | $29.71 | 2022 | |
| Acclarent, INC | $14.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.